Lakewood-Amedex Biotherapeutics financials
$0.1914−1.85%
Close Nov 4, 2026 · split-adjustedLakewood-Amedex Biotherapeutics has no annual financial statements on file. Funds and some foreign issuers do not file them.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology